ProfileGDS4718 / 239340_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 11% 7% 45% 10% 10% 7% 11% 5% 20% 7% 13% 16% 8% 3% 7% 18% 15% 9% 5% 8% 12% 16% 11% 8% 14% 4% 7% 3% 5% 6% 8% 10% 9% 10% 5% 8% 7% 5% 6% 33% 13% 6% 4% 4% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8474211
GSM549102patient 115, normal, homogenized [OPG study]3.661697
GSM549104patient 119, normal, homogenized [OPG study]5.2589745
GSM549108patient 138, normal, homogenized [OPG study]3.8041110
GSM549119patient 077, normal, homogenized [OPG study]3.7815510
GSM549133patient 032, cancer, homogenized [OPG study]3.635537
GSM549139patient 042, cancer, homogenized [OPG study]3.7824911
GSM549099patient 107, normal, homogenized [OPG study]3.598975
GSM549109patient 139, normal, homogenized [OPG study]4.1781520
GSM549110patient 046, normal, homogenized [OPG study]3.656347
GSM549114patient 063, normal, homogenized [OPG study]3.8679713
GSM549122patient 082, normal, homogenized [OPG study]4.0143616
GSM549134patient 033, cancer, homogenized [OPG study]3.688458
GSM549136patient 036, cancer, homogenized [OPG study]3.460663
GSM549140patient 044, cancer, homogenized [OPG study]3.646297
GSM549111patient 047, normal, homogenized [OPG study]4.0444418
GSM549113patient 057, normal, homogenized [OPG study]3.9128415
GSM549132patient 031, cancer, homogenized [OPG study]3.743669
GSM549137patient 038, cancer, homogenized [OPG study]3.564455
GSM549142patient 047, cancer, homogenized [OPG study]3.762338
GSM549100patient 110, normal, homogenized [OPG study]3.8710412
GSM549107patient 135, normal, homogenized [OPG study]3.9607316
GSM549115patient 068, normal, homogenized [OPG study]3.7821411
GSM549116patient 072, normal, homogenized [OPG study]3.693438
GSM549120patient 078, normal, homogenized [OPG study]3.9072514
GSM549131patient 030, cancer, homogenized [OPG study]3.494614
GSM549118patient 074, normal, homogenized [OPG study]3.683097
GSM549129patient 027, cancer, homogenized [OPG study]3.488173
GSM549123patient 088, normal, homogenized [OPG study]3.621285
GSM549124patient 006, cancer, homogenized [OPG study]3.637126
GSM549126patient 015, cancer, homogenized [OPG study]3.668488
GSM549128patient 025, cancer, homogenized [OPG study]3.7461710
GSM549103patient 117, normal, homogenized [OPG study]3.768839
GSM549117patient 073, normal, homogenized [OPG study]3.776810
GSM549138patient 041, cancer, homogenized [OPG study]3.561495
GSM549141patient 045, cancer, homogenized [OPG study]3.66858
GSM549130patient 028, cancer, homogenized [OPG study]3.659797
GSM549101patient 111, normal, homogenized [OPG study]3.555445
GSM549105patient 128, normal, homogenized [OPG study]3.635096
GSM549106patient 134, normal, homogenized [OPG study]4.6325533
GSM549112patient 048, normal, homogenized [OPG study]3.8833213
GSM549125patient 011, cancer, homogenized [OPG study]3.599816
GSM549127patient 024, cancer, homogenized [OPG study]3.523344
GSM549135patient 035, cancer, homogenized [OPG study]3.513094